Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.

Pandey, Sony; Bourn, Jennifer; Cekanova, Maria

Pandey, Sony; Bourn, Jennifer; Cekanova, Maria.

Afiliación

Pandey S; Department of Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee 37996, USA.
Bourn J; Department of Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee 37996, USA.
Cekanova M; UT-ORNL Graduate School of Genome Science and Technology, The University of Tennessee, Knoxville, Tennessee 37996, USA.

Oncotarget ; 9(47): 28514-28531, 2018 Jun 19.

Article en En | MEDLINE | ID: mdl-29983877

Palabras clave

AD 198; AD 312; PRIMA-1; bladder cancer; p53 siRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google